Food, drugs, devices › Bard Access Systems
Device recall: Marketing brochures for the PowerPICC and PowerPICC SOLO catheters
Bard Access Systems (Salt Lake City, UT) initiated this device recall on 20 Jul 2015; FDA lists 1 product record under event 71757, classified Class II.
FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 91% of the 1,153 device enforcement events initiated in 2015 carry the same class.
Status: Terminated, terminated 10 Feb 2017. Initiation: voluntary: firm initiated. Bard Access Systems has 13 enforcement events on this register, with a median of 1 product record per event.
Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.
Recalling firm
Bard Access Systems, Salt Lake City, UT.
Reason for recall
"Bard Access Systems is recalling marketing brochures for the PowerPICC¿ and PowerPICC¿ SOLO¿ catheters due to incorrect indication for use contained in the brochure."
Distribution
"Distributed to domestic and foreign conference attendees."
Product records
| Recall number | Product | Quantity | Class | Status | Report date |
|---|---|---|---|---|---|
| Z-2808-2015 | Marketing brochures for the PowerPICC and PowerPICC SOLO catheters | 1811 | Class II | Terminated | 30 Sep 2015 |
Context
Other enforcement events for Bard Access Systems
All 13 events for Bard Access Systems
Questions and answers
Why was this device recalled?
FDA's record gives the reason for recall as: "Bard Access Systems is recalling marketing brochures for the PowerPICC¿ and PowerPICC¿ SOLO¿ catheters due to incorrect indication for use contained in the brochure."
What does Class II mean?
FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Where was the product distributed?
FDA's distribution pattern field reads: "Distributed to domestic and foreign conference attendees."
Is the recall still ongoing?
FDA lists the status as Terminated; the termination date is 10 Feb 2017. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.
Where does this data come from?
openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.
Provenance
Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.